SMTL ID : 5v61.1

Phospho-ERK2 bound to bivalent inhibitor SBP2

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

hetero-1-1-mer

Ligands

3 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 2 residues within 4Å: Chain A: L.230, Y.259 No protein-ligand interaction detected (PLIP) GOL.2: 3 residues within 4Å: Chain A: P.315, S.316, E.318 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:P.315 GOL.3: 3 residues within 4Å: Chain A: D.175, F.179, F.327 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:D.175

1 x FRZ: 5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE(Non-covalent)

FRZ.4: 15 residues within 4Å: Chain A: Y.32, V.35, A.48, I.49, K.50, I.80, I.99, Q.101, D.102, L.103, M.104, N.150, L.152, D.163 Ligands: 90A.5 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:Y.32, A:V.35, A:K.50, A:K.50, A:I.99, A:Q.101, A:L.152, A:D.163 Hydrogen bonds: A:Q.101, A:M.104

1 x 90A: 2-oxo-6,9,12,15-tetraoxa-3-azaoctadecan-18-oic acid(Covalent)

90A.5: 7 residues within 4Å: Chain A: L.103, M.104, E.105, K.110, T.114 Chain B: T.1 Ligands: FRZ.4 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:L.103 Hydrogen bonds: A:K.110

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lechtenberg, B.C. et al., Structure-Guided Strategy for the Development of Potent Bivalent ERK Inhibitors. ACS Med Chem Lett (2017)

Release Date

2017-07-26

Peptides

Mitogen-activated protein kinase 1: A
Ribosomal protein S6 kinase alpha-1,Protein Tat: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
I

Mitogen-activated protein kinase 1

Ribosomal protein S6 kinase alpha-1,Protein Tat

Related Entries With Identical Sequence